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Abstract 
Specimens taken at surgery from 15 patients with 
carcinoma of the esophagus were examined with scan-
ning electron microscopy. Nine patients were treated 
with chemotherapy (cisplatin + 5-fluorouracil), surgery 
and radiotherapy; one received preoperative radiotherapy 
only; and the remaining five primary surgery only. 
Scanning electron microscopy was performed on speci-
mens of both tumor tissue and the mucosa at least 5 cm 
from the tumor. In adjacent non-tumor tissue, damage 
due to treatment was observed in the form of changes in 
microridges and increased cell loss. In tumor tissue, the 
degree of damage was correlated to tumor response to 
treatment. For patients with no residual tumor after 
treatment, the ultrastructure was normalized with a low 
tumor score, while for patients with residual tumor, the 
score was high. 
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Introduction 
In squamous cell carcinoma of the esophagus, ear-
lier treatment strategies of either radiotherapy alone or 
surgery alone (Earlam and Cunha-Melo, 1980a,b) have 
given way to multimodal forms of treatment in an at-
tempt to improve the otherwise gloomy prognosis. 
At the Department of Oncology, University Hos-
pital, Lund, a phase II trial was carried out during the 
period 1984-1988, in which patients with esophageal 
squamous cell carcinoma were pretreated with three 
courses of cytostatics (cisplatin + 5-fluorouracil) fol-
lowed by radiotherapy and surgery. Not only was the 
treatment well tolerated but, as compared with earlier 
published results, the outcome manifested improvement 
both in terms of palliation and survival rates (Mercke et 
al., 1991). In order to intensify treatment, the pre-
operative radiotherapy was given together with the third 
course of chemotherapy. The rationale for this derived 
from findings in an earlier series of animal experiments 
where rabbits underwent cisplatin treatment and irradia-
tion of the superior mediastinum, and where damage, 
proliferation and reparative effects in normal tissue were 
investigated, recovery being found to be better and more 
rapid in those parts of the trachea and esophagus ex-
posed to the combined treatment than in unexposed areas 
(Albertsson et al., 1992). 
In the present study, scanning electron microsco-
py (SEM) was performed on a number of patients con-
secutively treated for esophageal cancer at our depart-
ment in order to study the effect of treatment both on the 
tumor and the surrounding mucosa. For comparison, we 
examined specimens from five patients treated with pri-
mary surgery alone. The aim of the study was to assess 
damage and proliferation in tumor and normal mucosa! 
tissue, and if possible ascertain whether any correlation 
existed between treatment and clinicopathological out-
come variables. 
Materials and Methods 
The clinical characteristics of the 15 patients with 
esophageal cancer, either squamous cell carcinoma (n = 
13) or adenocarcinoma (n = 2), are shown in Table 1. 
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The patients were divided into three groups, according 
to their treatment: 
1) Control group (n = 5, 1 female, 4 males), 
aged 61-86 years who underwent primary surgery with-
out any pretreatment. 
2) Standard treatment group (n = 7, all males), 
aged 60-68 years, treated with three cycles of chemo-
therapy and preoperative radiotherapy (24 Gy). 
Group 2a) Standard treatment, no residual tumor. 
Group 2b) Standard treatment, residual tumor. 
3) Pretreated group (n = 3, 2 females, 1 male), 
aged 66- 76 years, whose treatment deviated from that of 
the standard treatment group for one reason or another. 
Sampling 
Specimens for SEM were taken in conjunction 
with surgery. One specimen was taken from the tumor 
area (TA); if no residual tumor was visible at surgery, 
a specimen was taken from the area initially considered 
to be tumor-involved. In addition, for control purposes, 
a non-tumor area (NTA) specimen was taken from the 
esophageal mucosa at least 5 cm from the visible border 
of the tumor area. 
Treatment 
The treatment protocol consisted of three courses 
of chemotherapy followed by radiotherapy and surgery: 
Chemotherapy Chemotherapy consisted of cis-
platin [90-120 mg/m 2 BSA (body surface area)] on day 
1, and 5-fluorouracil (5-FU 1000 mg/m 2 BSA) daily in 
continuous infusion on days 1-5. Before cisplatin ad-
ministration, the patients were prehydrated with 1000 ml 
0.9% saline given as a 2-hour infusion. Cisplatin was 
dissolved in 2000 ml 0.9% saline and given together 
with 500 ml 15% mannitol as an intravenous infusion 
over four hours. Uresis was measured every fourth 
hour, diuretics being given if it was less than 400 ml for 
the 4-hour period. Treatment with 5-FU started immedi-
ately after completion of the cisplatin infusion, the 5-FU 
being dissolved in 2000 ml 0.9% saline and given as 
continuous 24-hour infusion for five consecutive days. 
Radiotherapy For patients with out metastasis, an 
absorbed dose of 64 Gy to the esophageal tumor (target 
volume I) was planned in two series as pre- and postop-
erative radiotherapy. In all cases, radiation therapy was 
given with 6 MY or 8 MY photons, using a linear accel-
erator. Target volume I was defined as the tumor dem-
onstrated at chest radiography or CT (computerized to-
mography). For tumors at or above the tracheal carina, 
the caudal border of target volume I was set 5 cm below 
the lower extension of the tumor, whereas its cranial 
border included the supraclavicular nodes. For these up-
per tumors, a 3-field approach was used both pre- and 
postoperatively. For tumors, the bulk of which was lo-
cated below the level of the carina, the cranial border 
was set to include 5 cm of radiographically uninvolved 
esophagus, whereas the celiac lymph nodes were includ-
ed in target volume II, and defined the caudal border of 
target volume I. 
Any affected nodes in the celiac region were 
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resected at surgery. If histopathologic examination 
showed the presence of viable malignant cells, the total 
absorbed dose was 40 Gy, otherwise only 24 Gy (i.e., 
only the preoperative radiotherapy was given). In the 
case of tumors below the tracheal carina, AP-PA (ante-
roposterior-posteroanterior) fields were used preopera-
tively (target volumes I and II); and postoperatively a 3-
field technique with one dorsal and two oblique portals 
was used for target volume I and AP-PA fields for target 
volume II with a specified dose of 40 Gy. The target-
absorbed dose was specified according to minimum ab-
sorbed dose. Daily fractionated radiation was given with 
a target dose of 2. 0 Gy. 
Surgery Surgery included laparotomy for inspec-
tion of liver and celiac nodes, the latter being resected 
if cancer was suspected. The stomach and the duodenum 
were mobilized and pyloromyotomy performed. The 
esophagus was resected through a right-sided thoracoto-
my, the stomach being pulled up into the chest and an 
anastomosis performed between the fundus and the prox-
imal esophagus. 
Specimen preparation for SEM 
Specimens for SEM were fixed in 2.5% glutaral-
dehyde (in 0.15 M cacodylate buffer, pH = 7.3) for 12 
hours, followed by postfixation in 1 % osmium tetroxide 
in 0.15 M cacodylate buffer for two hours. After dehy-
dration in a graded ethanol series and critical point 
drying, the specimens were sputter-coated with gold and 
examined in a Philips 515 SEM operated at 20 kV. 
Scoring system 
For evaluation of the specimens, the following 5-
point scoring system was used: 
Score 0: Normal epithelium. 
Score 1: Membrane damage with edema and exudate. 
Score 2: Damaged microridges manifesting the 'farci-
men phenomenon' (i.e., broken up into short 
segments linked like a string of sausages), 
nodules (knobs), fluid-containing vesicles 
(blebs) and other protrusions. 
Score 3: Ulceration, microridges rudimentary or lost. 
Score 4: Manifest destruction, no normal surface struc-
tures identifiable. 
From each specimen, at least ten different areas 
were evaluated by five independent observers. Corre-
sponding tumor and non-tumor specimens were rated ac-
cording to this scoring system, yielding a mean case 
score and mean group score (see Fig. 8, for results). 
Results 
Group 1. Control group 
SEM of esophageal mucosa specimens from the 
control group of patients undergoing no pretreatment 
(Table 1) showed polygonal cell flakes, arranged in 
regular patterns (Figures la-c). Cell borders were 
clearly identifiable, and did not protrude from the sur-
face of the mucosa. Some cell loss was usually seen, 
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Table 1. Clinical data from 15 patients with esophageal carcinoma. 
No. Age Sex Level Pathol Pretreatment Survival Score SEM Figures 
months Tumor area Non-tumor area 
Group 1 
1 75 M Low s 7 la, lb, le 
2 86 F Low s 11 
3 82 M Low A 5 4.0 1.37 2a, 2b, 2c 
3a, 3b, 3c 
4 62 M s 5 
5 61 M Low A 7 
Group 2a (standard treatment, no residual tumor) 
6 64 M Low s 3 (cht) + RT 24 Gy 5 
7 62 M Low s 3 (cht) + RT 24 Gy 24 1.5 1.12 4a-4e 
Group 2b (standard treatment, residual tumor) 
8 65 M Mid s 3 (cht) + RT 24 Gy 9 
9 60 M Mid s 3 (cht) + RT 24 Gy 29 
10 60 M Low s 3 (cht) + RT 24 Gy 40 3.0 2.0 5a, 5b 
11 68 M Up s 3 (cht) + RT 24 Gy 12 6a, 6b 
12 61 M Low s 3 (cht) + RT 24 Gy 26 
Group 3 
13 66 F Low s 1 (cht) + RT 40 Gy 16 
14 68 F Low s 1 (cht) + RT 24 Gy 7 3.5 2.0 
15 76 M Mid s RT 40 Gy 4 7a, 7b 
s = Squamous cell carcinoma; A= Adenocarcinoma; cht = chemotherapy; RT = radiotherapy. 
---------- ----- ------------------------ ------- --------------- --- -------------- - - -- --- ------- -- - - - -- ------
often occurring in flakes of groups of cells, but some-
times of whole single cells. Cell surfaces were covered 
with microridges, often parallel to each other but some-
times in whorled or convoluted configurations, the pat-
terns being homogeneous within a given cell but often 
varying from one cell to another. The microridges usu-
ally manifested small, barely discernible nodular irregu-
larities (Fig. lb). Occasionally the microridges ap-
peared to be swollen, manifesting the 'farcimen phenom-
enon' (Fig. le). Sometimes the nodular irregularities 
appeared to be distended, like small bullae, connected to 
the original microridges by fine 'stems'; and sometimes 
they had the form of a broad-based protrusions (Fig. 
2c). Occasionally microridges covered the greater part 
of the cell surface in the form of protrusions (Fig. 2b), 
and sometimes they were grouped in nidulate configura-
tions (Fig. 2a). Two of the patients in this group were 
found to have adenocarcinoma. The TA specimen of one 
of the two patients with adenocarcinoma manifested po-
lygonal cells outlined with short, stubby microvilli (Fig. 
3a). Occasionally a closed packed rim of microvilli 
could be seen surrounding a central area of mucus. In 
another area, the cells manifested marked bulging and 
their surfaces were covered with microvilli (Fig. 3b). 
For comparison, Fig. 3c shows the normal squamous 
epithelium in an NT A specimen from the same patient. 
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Group 2a (Standard treatment, patients with no 
residual tumor after preoperative treatment, n = 2) 
No malignant cells were identifiable within the 
original tumor area, specimens being similar to those 
from normal epithelium (NTA), though some differences 
could be observed. In TA specimens, cells were round-
ed and plaque-like, lying loosely on the surface (Fig. 
4a), without the interconnections seen between normal 
cells. In some areas the cells were swollen with edema 
and exudate (Fig. 4b); in others, the microridges were 
arranged in irregular configurations, being sometimes 
very closely packed, and manifesting the 'farcimen 
phenomenon' (Fig. 4c). Intercellular spaces took the 
form of cracks and fissures. No microorganisms were 
found. Figures 4d and 4e from the same patient present 
micrographs from non-tumor area. The cell borders are 
clearly defined (Fig. 4d) and microridges are arranged 
in regular patterns. 
Group 2b (Standard treatment, patients with residual 
tumor) 
TA specimens manifested pronounced heterogene-
ity in cell surface morphology. In some areas, no nor-
mal microridge patterns could be seen; some areas were 
completely denuded of microridges, and in other areas, 
they were present only in rudimentary form (Fig. 5a). 
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Electron microscopy of human esophageal mucosa 
Figure 1 (facing page, left). Scanning electron micro-
graphs of a non-tumor area (NT A) specimen from a 
group 1 (non-pretreated) patient (no. 1) with squamous 
cell carcinoma, showing: a) wrinkled epithelium, and 
exudate (arrow); b) mucus-containing bulges (arrow, B) 
and knobs from microridges (arrow, Kn); c) swollen 
microridges manifesting the 'farcimen phenomenon' 
(arrow) and cell borders raised in relief. 
Figure 2 (facing page, right). Micro graphs of an NT A 
specimen from a group 1 (non-pretreated) patient (no. 3) 
with adenocarcinoma, showing: a) clustered protrusions 
contained within a nidulate arrangement of microridges; 
b) protrusions; and c) central area of Fig. 2b, at a 
higher magnification. 
Figure 3 (at right). Micrographs of specimens from a 
group 1 (non-pretreated) patient (no. 3) with adenocarci-
noma: a) TA specimen showing cells with borders cov-
ered with microvilli; b) TA specimen, showing singular 
bulging cells, the entire surface of which is covered with 
microvilli; c) NTA specimen, showing swollen cell bor-
ders and microridges in regular arrangements. 
In the NT A specimen, cell borders were distinct and 
raised in relief, the cell surface manifesting regular pat-
terns of microridges (Fig. Sb). Microridges manifested 
great morphological variation from one area of a given 
cell to another, and there was no sign of the regular sur-
face pattern seen in normal cells. Normal cell borders 
were absent, intercellular spaces taking the form of 
cracks and fissures. In some cases, abnormalities of cell 
surface morphology were manifested, with no normal 
features remaining (cf. Figures 6a and 6b). In TA 
specimens, cells manifested gross superficial destruc-
tion, with filamentous processes extending across the 
surface (Fig. 6a); cell borders could not be discerned. 
In NTA specimens, the surface was covered with short, 
stubby microridges of a nodular appearance (Fig. 6b), 
which could be verified by transmission electron micros-
copy (TEM). 
Group 3 
For patient number 15, given preoperative radio-
therapy ( 40 Gy) but no chemotherapy, the TA specimen 
manifested gross superficial destruction, and no normal 
cell structures could be discerned (Fig. 7a). His NTA 
specimen showed slight treatment damage, manifesting 
edema, exudate and a somewhat wrinkled epithelium 
(Fig. 7b). 
From the scoring results shown in Fig. 8, it can 
be seen that for group 1 (i.e., patients who underwent 
surgery only) the NT A score was just over 1, and the 
TA score 4. For patients with no residual tumor after 
preoperative treatment (n = 2), the TA score was 1.5 
and the NT A score 1. 1. For patients with residual 
tumor at surgery, the NT A score (2. 0) was higher than 
in the other two groups, and the TA score was markedly 
higher, 3.0 in group 2b and 3.5 in group 3. 
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Figure 4. Micrographs of specimens from a group 2a (pretrea-
ted) patient (no. 7) with no residual tumor at surgery: a) TA 
specimen showing plaque-like epithelial cells in singular forma-
tions; b) TA specimen showing swollen cells with disrupted mi-
croridges, edema and exudate (arrow), the microridge abnormali-
ty presumably being attributable to treatment; c) an area from 
Fig. 3b at a higher magnification, showing densely packed micro-
ridges with the farcimen phenomenon (arrows), and microridges 
in irregular patterns; d and e) NTA specimen showing normal 
microridges in regular patterns and clearly defined cell borders. 
Figures S and 6 (on facing page). Micro graphs of specimens 
from group 2b (pretreated) patients (no. 10, Figure S; and no. 
11, Figure 6) with residual tumor at surgery: Fig. Sa) TA 
specimen showing cells with microridges almost absent or only 
present in rudimentary form (arrows); Fig. Sb) NTA specimen 
showing slightly damaged microridges, and cell borders with 
exudate (arrow); Fig. 6a) TA specimen, showing heavy surface 
destruction; and Fig. 6b) NTA specimen, showing the surface 
covered with short, stubby microridges. 
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Electron microscopy of human esophageal mucosa 
Figure 7. Micrographs of specimens from a group 3 (non-standard pretreatment) patient (no. 15) with residual tumor at 
surgery: a) TA specimen, showing heavy surface destruction; b) NT A specimen, showing wrinkled epithelium, and exudate. 
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Group 1 Group 2a Group 2b Group 3 
Figure 8. Mean scores for tumor area (hatched) and non tumor area (unhatched) specimens in groups 1, 2 and 3. 
Discussion 
It has been a time-honored axiom in cancer thera-
py that the two principal treatment modalities, chemo-
therapy and radiotherapy, should not be given simulta-
neously but staggered to avoid unacceptable high toxicity 
in normal tissue. However, in squamous cell carcinoma 
of the esophagus, earlier treatment strategies of either 
radiotherapy alone or surgery alone (Earlam and Cunha-
Melo, 1980a,b) have given way to multimodal forms of 
treatment comprising chemotherapy, radiotherapy and 
surgery (Launois et al., 1981; EORTC, 1985; Kelsen 
1985; Carey et al., 1986; Popp et al., 1986; Leichman 
et al., 1987; Hambraeus et al., 1988; Forastiere et al., 
1990; Herskovic et al., 1992), an approach introduced 
with a view to improving both local control and the oth-
erwise gloomy prognosis associated with this disease. 
The recently reported treatment of esophageal 
cancer with three cycles of chemotherapy combined with 
radiotherapy and surgery has yielded promising results 
(Mercke et al., 1991). In the present study, specimens 
from 15 patients were examined by SEM to obtain fur-
ther information. Specimens from five of the patients, 
who had undergone surgery only (without pretreatment), 
were selected for use as controls; however, their NT A 
specimens were not found to be completely normal 
according to previously published morphological data 
(Ackerman et al., 1976; Robinson et al., 1981). In 
those studies, normal esophageal mucosa is described as 
a flat surface overlaid with polygonal epithelial cells and 
regular patterns of microridges. 
In the present patients, the surface adjacent to the 
tumor area was wrinkled or folded, and the microridges 
were not completely normal but manifested protrusions 
of various kinds and sizes. A fairly common finding 
was the presence of small nodular irregularities of the 
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membrane that apparently developed, becoming distend-
ed either like small balloons and attached to the micro-
ridges by stem-like processes, or in the form of a broad 
based protrusions arranged in structured groups or cov-
ering a portion of the surface area (Figures 2a-c). Al-
though at first glance it might seen reasonable to inter-
pret these changes in microridge morphology as damage 
attributable to treatment (e.g., chemotherapy or radio-
therapy), they were also seen in untreated cases and may 
well constitute a non-specific degenerative process 
associated with any of a variety of factors. 
The specimen shown in Fig. 2 is from the esopha-
geal mucosa of an 82 year old man with adenocarcinoma 
of the esophagus who underwent primary surgery only 
(i.e., no pretreatment with chemotherapy or radiothera-
py); in this case, the microridge degeneration may con-
stitute, wholly or partly, an expression of the normal 
ageing process. Moreover, as patients treated for esoph-
agus cancer commonly manifest a weight loss of 5-15 kg 
(11-33 lbs) at diagnosis, and often loose more weight 
during treatment, it is not impossible that this weight 
loss and dehydration also affect the esophageal mucosa, 
perhaps explaining the wrinkled superficial appearance. 
Ackerman et al. (1976) reported that the superfi-
cial microridges seen in SEM correlate well with the 
short cytoplasmic processes of superficial mucosa! cells 
seen in TEM. The microridges are believed to be of 
functional importance in maintaining epithelial integrity, 
cellular contact being enhanced by interdigitation. An 
early observable change is that the microridges swell, 
increasing in diameter, and manifesting what we have 
termed the 'farcimen phenomenon' (i.e., the microridge 
is broken up into short segments, resembling a string of 
sausages). A similar phenomenon is seen in very small 
blood vessels exposed to radiation, and is said to be due 
to the swelling of endothelial cells. Microridges have no 
Electron microscopy of human esophageal mucosa 
connection to endothelial cells, and it is not known 
whether there is any cytoplasmic content. However, 
they form abundant connections (desmosomes) with 
overlying or underlying cell layers. 
In those group 2a cases, where no residual tumor 
was found at surgery (n = 2), the esophageal mucosa in 
the original tumor area was normalized, as reflected in 
the mean scores for these patients (Fig. 8) which were 
very close to the NT A scores for group 1 patients who 
underwent surgery only (i.e., no chemotherapy or radio-
therapy pretreatment). 
All the normal structures can be identified in TA 
specimens (Figures 4a-c). An abnormal finding was that 
of loose cells on the cell surface, which may be attribut-
able to an effect of the treatment on desmosomes, an is-
sue that we shall be investigating in further studies using 
TEM. 
Group 2b patients, who had undergone pretreat-
ment but manifested residual tumor at surgery (Figures 
Sa Sb, 6a and 6b), had higher mean scores both in TA 
and NT A specimens (Fig. 8). Although this finding is 
striking, it should be borne in mind that the series is too 
small to allow any firm conclusions to be drawn, other 
than that perhaps group 2b patients constitute worse 
cases generally, something that equally applies to group 
3 patients (Figures 7a and 7b). 
Concerning the abnormal morphology of tumor 
cells, with microridges absent or only present in rudi-
mentary form, the presence of poorly defined micro-
ridges has previously been reported both in reflux esoph-
agitis (Dilly and Mallinson, 1975) and in preneoplastic 
and neoplastic lesions (Williams et al., 1973). More-
over, both the reduction in the number of microridges 
and their less regular arrangement, as seen on malignant 
esophageal cells in the present study, have been de-
scribed previously and interpreted as possibly due to the 
rapid growth and turnover of malignant cells (Siew and 
Goldstein, 1981). In the present study, no correlation 
was found between tumor score and survival. 
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Discussion with Reviewers 
S. Siew: You state that in cases with no visible residual 
tumor, specimens were taken from the area initially con-
sidered to be tumor involved. By what means had such 
areas been identified to have been involved prior to 
therapy? 
Authors: All patients were thoroughly investigated and 
pretherapy staging was based on clinical history and ex-
amination, barium radiography of esophagus, esophagos-
copy, chest radiography, CT of thorax and upper abdo-
men, blood count and serum tests of liver function. All 
these examinations were repeated after chemotherapy 
and radiotherapy for evaluation of response. 
S. Siew: Did you examine the tissues by means of light 
microscopy? If so, what was the correlation between the 
histopathologic and scanning electron microscopic find-
ings? More particularly, in the 2 cases with no visible 
gross tumor, was there evidence of tumor on microscop-
ic examination? 
Authors: Immediately after surgery, all the tissues were 
examined with light microscopy, and also later on with 
TEM, results of which will be presented at a later date. 
In the 2 cases with no visible gross tumor, there was no 
evidence of tumor on light microscopic examination. 
S. Siew: You have shown that there was no correlation 
between the tumor score and survival (Table 1). How-
ever, other factors have to be taken into consideration 
such as the fact that esophageal tumors often spread be-
neath the mucosa. In such cases, the overlying mucosa 
would have a spuriously normal appearing surface. Fur-
ther, depth of invasion and metastasis, regional and 
distant, determine the length of survival. 
Authors: Your are absolutely correct and for this rea-
son, all patients were thoroughly examined (see answer 
to your first question above). Other investigations have 
indicated that a complete response to chemotherapy is 
strongly associated with a prolonged disease-free surviv-
al (Rooney et al., 1985; Al Kourainy et al., 1987; 
Jacobs et al., 1987; Thomas et al., 1988). Unfortunately 
in our study, the group of patients (n = 2) with no re-
sidual tumor after treatment died in intercurrent deaths. 
One of the patients died after five months in pulmonary 
embolism and autopsy showed no tumor. Also the other 
patient with no residual tumor after pretreatment, died 
in intercurrent death and again autopsy showed no re-
sidual tumor. 
S. Siew: There were 2 cases of adenocarcinoma. Did 
they show similar findings? Your micrographs (Figures 
2a-c and 3a-c) are from one and the same case: Figures 
2a-c and 3c being of non-tumor affected tissue and Fig-
ures 3a and 3b from the tumor. Do you not consider 
that the appearance of Figures 3a and 3b, with the pres-
ence of microvilli and "bulging" cells, is in keeping with 
that of a poorly differentiated adenocarcinoma and that 
the bulging of the cells is due to the fact that they are 
942 
columnar? 
Authors: Yes, the findings were similar in the two 
cases with adenocarcinoma and I find your interpretation 
of the micrographs interesting and absolutely right. 
S. Siew: As Barrett's esophagus is an important predis-
posing factor of esophageal carcinoma, did you see evi-
dence of that in your cases? 
Authors: Barrett's esophagus is an important predispos-
ing factor only for adenocarcinoma and we did have two 
cases of adenocarcinoma in this study; we did find evi-
dence of Barrett's esophagus in one of these cases. 
S. Siew: Figure 7a illustrates the SEM findings in a 
patient who had residual tumor after one course of radio-
therapy. Are you able to differentiate the degree of 
damage inflicted by radiotherapy in the production of the 
heavy surface destruction? 
Authors: Unfortunately we could not differentiate the 
damage. However, the exudation on the surface and the 
fibrin-like network could be associated to radiation 
damage. 
M.J.A. Cornelissen: Since you mention in your Intro-
duction that the aim of the study is to assess prolifera-
tion, would it not be appropriate to have an estimation 
of proliferation capacity after treatment by using pro! if e-
ration markers. Please comment and give some sugges-
tions. 
Authors: You are absolutely correct. In future, we are 
planning to investigate the proliferation capacity for the 
tumors with BuDR before, and also after, treatment. 
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